It turns out that the human diacylglycerol kinase epsilon (DGKE) mutation (291), a cause of the hemolytic uremic syndrome, also reflects inhibition of VEGF signaling and consequent de-differentiation of glomerular EC (292). This evidence concerns the gene VEGFA and hemolytic-uremic syndrome.